25 XP   0   0   10

Enzychem Lifesciences Corporation
Buy, Hold or Sell?

Let's analyse Enzychem Lifesciences Corporation together

PenkeI guess you are interested in Enzychem Lifesciences Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Enzychem Lifesciences Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Enzychem Lifesciences Corporation

I send you an email if I find something interesting about Enzychem Lifesciences Corporation.

Quick analysis of Enzychem Lifesciences Corporation (30 sec.)










What can you expect buying and holding a share of Enzychem Lifesciences Corporation? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,287.96
Expected worth in 1 year
₩2,182.41
How sure are you?
23.5%

+ What do you gain per year?

Total Gains per Share
₩-105.55
Return On Investment
-6.0%

For what price can you sell your share?

Current Price per Share
₩1,760.00
Expected price per share
₩1,505 - ₩2,290
How sure are you?
50%

1. Valuation of Enzychem Lifesciences Corporation (5 min.)




Live pricePrice per Share (EOD)

₩1,760.00

Intrinsic Value Per Share

₩17,025.75 - ₩20,718.23

Total Value Per Share

₩19,313.71 - ₩23,006.19

2. Growth of Enzychem Lifesciences Corporation (5 min.)




Is Enzychem Lifesciences Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?$136.2m$149.2m-$11.3m-8.2%

How much money is Enzychem Lifesciences Corporation making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$4.3m$2.7m169.1%
Net Profit Margin-12.7%-94.9%--

How much money comes from the company's main activities?

3. Financial Health of Enzychem Lifesciences Corporation (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#188 / 393

Most Revenue
#308 / 393

Most Profit
#330 / 393

Most Efficient
#338 / 393

What can you expect buying and holding a share of Enzychem Lifesciences Corporation? (5 min.)

Welcome investor! Enzychem Lifesciences Corporation's management wants to use your money to grow the business. In return you get a share of Enzychem Lifesciences Corporation.

What can you expect buying and holding a share of Enzychem Lifesciences Corporation?

First you should know what it really means to hold a share of Enzychem Lifesciences Corporation. And how you can make/lose money.

Speculation

The Price per Share of Enzychem Lifesciences Corporation is ₩1,760. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Enzychem Lifesciences Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Enzychem Lifesciences Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,287.96. Based on the TTM, the Book Value Change Per Share is ₩-26.39 per quarter. Based on the YOY, the Book Value Change Per Share is ₩224.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Enzychem Lifesciences Corporation.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.020.0%-0.020.0%-0.050.0%-0.150.0%-0.150.0%
Usd Book Value Change Per Share-0.010.0%-0.020.0%0.160.0%0.090.0%0.090.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.010.0%-0.020.0%0.160.0%0.090.0%0.090.0%
Usd Price Per Share1.27-1.24-8.61-111.77-111.77-
Price to Earnings Ratio-21.10--16.59--43.68--114.23--114.23-
Price-to-Total Gains Ratio-194.72--92.38--67.50--158.03--158.03-
Price to Book Ratio0.79-0.77-4.69-34.13-34.13-
Price-to-Total Gains Ratio-194.72--92.38--67.50--158.03--158.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.232
Number of shares811
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.09
Usd Total Gains Per Share-0.020.09
Gains per Quarter (811 shares)-14.9876.40
Gains per Year (811 shares)-59.92305.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-60-700306296
20-120-1300611602
30-180-1900917908
40-240-250012221214
50-300-310015281520
60-360-370018341826
70-419-430021392132
80-479-490024452438
90-539-550027512744
100-599-610030563050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%4.013.00.023.5%4.013.00.023.5%4.013.00.023.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%4.013.00.023.5%4.013.00.023.5%4.013.00.023.5%

Fundamentals of Enzychem Lifesciences Corporation

About Enzychem Lifesciences Corporation

  • Other

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Enzychem Lifesciences Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Enzychem Lifesciences Corporation earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • A Net Profit Margin of -7.9% means that ₩-0.08 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Enzychem Lifesciences Corporation:

  • The MRQ is -7.9%. The company is making a loss. -1
  • The TTM is -12.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7.9%TTM-12.7%+4.8%
TTM-12.7%YOY-94.9%+82.2%
TTM-12.7%5Y-73.2%+60.5%
5Y-73.2%10Y-73.2%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%4.5%-12.4%
TTM-12.7%5.5%-18.2%
YOY-94.9%6.8%-101.7%
5Y-73.2%6.0%-79.2%
10Y-73.2%6.1%-79.3%
1.1.2. Return on Assets

Shows how efficient Enzychem Lifesciences Corporation is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • -0.9% Return on Assets means that Enzychem Lifesciences Corporation generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Enzychem Lifesciences Corporation:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-1.1%+0.2%
TTM-1.1%YOY-2.3%+1.3%
TTM-1.1%5Y-3.7%+2.6%
5Y-3.7%10Y-3.7%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%1.0%-1.9%
TTM-1.1%1.1%-2.2%
YOY-2.3%1.5%-3.8%
5Y-3.7%1.3%-5.0%
10Y-3.7%1.4%-5.1%
1.1.3. Return on Equity

Shows how efficient Enzychem Lifesciences Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • -0.9% Return on Equity means Enzychem Lifesciences Corporation generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Enzychem Lifesciences Corporation:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-1.2%+0.2%
TTM-1.2%YOY-3.0%+1.8%
TTM-1.2%5Y-5.0%+3.8%
5Y-5.0%10Y-5.0%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%3.1%-4.0%
TTM-1.2%3.3%-4.5%
YOY-3.0%5.0%-8.0%
5Y-5.0%3.9%-8.9%
10Y-5.0%3.9%-8.9%

1.2. Operating Efficiency of Enzychem Lifesciences Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Enzychem Lifesciences Corporation is operating .

  • Measures how much profit Enzychem Lifesciences Corporation makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Enzychem Lifesciences Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-24.5%+24.5%
5Y-24.5%10Y-24.5%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-10.9%
TTM-9.5%-9.5%
YOY-8.9%-8.9%
5Y-24.5%6.0%-30.5%
10Y-24.5%7.3%-31.8%
1.2.2. Operating Ratio

Measures how efficient Enzychem Lifesciences Corporation is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 2.09 means that the operating costs are ₩2.09 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Enzychem Lifesciences Corporation:

  • The MRQ is 2.089. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.133. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.089TTM2.133-0.044
TTM2.133YOY2.461-0.328
TTM2.1335Y2.549-0.416
5Y2.54910Y2.5490.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0891.258+0.831
TTM2.1331.260+0.873
YOY2.4611.215+1.246
5Y2.5491.257+1.292
10Y2.5491.358+1.191

1.3. Liquidity of Enzychem Lifesciences Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Enzychem Lifesciences Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 12.33 means the company has ₩12.33 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Enzychem Lifesciences Corporation:

  • The MRQ is 12.327. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.847. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.327TTM12.847-0.520
TTM12.847YOY4.497+8.350
TTM12.8475Y8.100+4.747
5Y8.10010Y8.1000.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3271.437+10.890
TTM12.8471.507+11.340
YOY4.4971.531+2.966
5Y8.1001.478+6.622
10Y8.1001.478+6.622
1.3.2. Quick Ratio

Measures if Enzychem Lifesciences Corporation is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • A Quick Ratio of 9.43 means the company can pay off ₩9.43 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Enzychem Lifesciences Corporation:

  • The MRQ is 9.432. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.797. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.432TTM10.797-1.364
TTM10.797YOY4.136+6.660
TTM10.7975Y6.752+4.045
5Y6.75210Y6.7520.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ9.4320.552+8.880
TTM10.7970.604+10.193
YOY4.1360.603+3.533
5Y6.7520.608+6.144
10Y6.7520.603+6.149

1.4. Solvency of Enzychem Lifesciences Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Enzychem Lifesciences Corporation assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Enzychem Lifesciences Corporation to Other industry mean.
  • A Debt to Asset Ratio of 0.08 means that Enzychem Lifesciences Corporation assets are financed with 8.0% credit (debt) and the remaining percentage (100% - 8.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Enzychem Lifesciences Corporation:

  • The MRQ is 0.080. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.086. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.086-0.006
TTM0.086YOY0.213-0.128
TTM0.0865Y0.219-0.133
5Y0.21910Y0.2190.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.531-0.451
TTM0.0860.527-0.441
YOY0.2130.545-0.332
5Y0.2190.559-0.340
10Y0.2190.570-0.351
1.4.2. Debt to Equity Ratio

Measures if Enzychem Lifesciences Corporation is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • A Debt to Equity ratio of 8.7% means that company has ₩0.09 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Enzychem Lifesciences Corporation:

  • The MRQ is 0.087. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.094. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.094-0.007
TTM0.094YOY0.272-0.178
TTM0.0945Y0.314-0.220
5Y0.31410Y0.3140.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0871.082-0.995
TTM0.0941.074-0.980
YOY0.2721.166-0.894
5Y0.3141.294-0.980
10Y0.3141.460-1.146

2. Market Valuation of Enzychem Lifesciences Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Enzychem Lifesciences Corporation generates.

  • Above 15 is considered overpriced but always compare Enzychem Lifesciences Corporation to the Other industry mean.
  • A PE ratio of -21.10 means the investor is paying ₩-21.10 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Enzychem Lifesciences Corporation:

  • The EOD is -20.426. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.099. Based on the earnings, the company is expensive. -2
  • The TTM is -16.586. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.426MRQ-21.099+0.673
MRQ-21.099TTM-16.586-4.514
TTM-16.586YOY-43.679+27.094
TTM-16.5865Y-114.235+97.649
5Y-114.23510Y-114.2350.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-20.42613.358-33.784
MRQ-21.09910.764-31.863
TTM-16.58610.593-27.179
YOY-43.67911.234-54.913
5Y-114.23511.224-125.459
10Y-114.23512.409-126.644
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Enzychem Lifesciences Corporation:

  • The EOD is -14.504. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.982. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.547. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.504MRQ-14.982+0.478
MRQ-14.982TTM-12.547-2.434
TTM-12.547YOY-41.448+28.901
TTM-12.5475Y-150.026+137.479
5Y-150.02610Y-150.0260.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-14.5044.534-19.038
MRQ-14.9824.168-19.150
TTM-12.5475.228-17.775
YOY-41.4481.587-43.035
5Y-150.0261.673-151.699
10Y-150.0263.531-153.557
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Enzychem Lifesciences Corporation is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 0.79 means the investor is paying ₩0.79 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Enzychem Lifesciences Corporation:

  • The EOD is 0.769. Based on the equity, the company is cheap. +2
  • The MRQ is 0.795. Based on the equity, the company is cheap. +2
  • The TTM is 0.766. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.769MRQ0.795-0.025
MRQ0.795TTM0.766+0.028
TTM0.766YOY4.692-3.926
TTM0.7665Y34.133-33.367
5Y34.13310Y34.1330.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD0.7691.696-0.927
MRQ0.7951.357-0.562
TTM0.7661.354-0.588
YOY4.6921.444+3.248
5Y34.1331.486+32.647
10Y34.1331.604+32.529
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Enzychem Lifesciences Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.336-26.387+183%224.978-104%134.586-107%134.586-107%
Book Value Per Share--2287.9602316.753-1%2540.329-10%3675.054-38%3675.054-38%
Current Ratio--12.32712.847-4%4.497+174%8.100+52%8.100+52%
Debt To Asset Ratio--0.0800.086-7%0.213-63%0.219-63%0.219-63%
Debt To Equity Ratio--0.0870.094-7%0.272-68%0.314-72%0.314-72%
Dividend Per Share----0%-0%-0%-0%
Eps---21.541-27.409+27%-74.707+247%-214.186+894%-214.186+894%
Free Cash Flow Per Share---30.337-36.914+22%-66.546+119%-210.518+594%-210.518+594%
Free Cash Flow To Equity Per Share---30.337-36.914+22%-66.546+119%-210.518+594%-210.518+594%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20718.225--------
Intrinsic Value_10Y_min--17025.751--------
Intrinsic Value_1Y_max---95.452--------
Intrinsic Value_1Y_min---95.034--------
Intrinsic Value_3Y_max--1368.187--------
Intrinsic Value_3Y_min--1272.774--------
Intrinsic Value_5Y_max--4827.094--------
Intrinsic Value_5Y_min--4337.943--------
Market Cap--154649191716.000151055171721.500+2%1029174189471.064-85%2692161047613.216-94%2692161047613.216-94%
Net Profit Margin---0.079-0.127+61%-0.949+1102%-0.732+827%-0.732+827%
Operating Margin----0%-0%-0.2450%-0.2450%
Operating Ratio--2.0892.133-2%2.461-15%2.549-18%2.549-18%
Pb Ratio0.769-3%0.7950.766+4%4.692-83%34.133-98%34.133-98%
Pe Ratio-20.426+3%-21.099-16.586-21%-43.679+107%-114.235+441%-114.235+441%
Price Per Share1760.000-3%1818.0001775.750+2%12302.502-85%159676.593-99%159676.593-99%
Price To Free Cash Flow Ratio-14.504+3%-14.982-12.547-16%-41.448+177%-150.026+901%-150.026+901%
Price To Total Gains Ratio-188.511+3%-194.723-92.376-53%-67.502-65%-158.032-19%-158.032-19%
Quick Ratio--9.43210.797-13%4.136+128%6.752+40%6.752+40%
Return On Assets---0.009-0.011+25%-0.023+171%-0.037+323%-0.037+323%
Return On Equity---0.009-0.012+26%-0.030+213%-0.050+427%-0.050+427%
Total Gains Per Share---9.336-26.387+183%224.978-104%134.586-107%134.586-107%
Usd Book Value--136238649.484137953105.094-1%149253247.420-9%89111348.867+53%89111348.867+53%
Usd Book Value Change Per Share---0.007-0.018+183%0.157-104%0.094-107%0.094-107%
Usd Book Value Per Share--1.6021.622-1%1.778-10%2.573-38%2.573-38%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.015-0.019+27%-0.052+247%-0.150+894%-0.150+894%
Usd Free Cash Flow---1806467.642-2198052.666+22%-3908200.520+116%-3304670.100+83%-3304670.100+83%
Usd Free Cash Flow Per Share---0.021-0.026+22%-0.047+119%-0.147+594%-0.147+594%
Usd Free Cash Flow To Equity Per Share---0.021-0.026+22%-0.047+119%-0.147+594%-0.147+594%
Usd Market Cap--108254434.201105738620.205+2%720421932.630-85%1884512733.329-94%1884512733.329-94%
Usd Price Per Share1.232-3%1.2731.243+2%8.612-85%111.774-99%111.774-99%
Usd Profit---1282678.586-1632122.014+27%-4391294.199+242%-3401516.985+165%-3401516.985+165%
Usd Revenue--16247702.90513306806.433+22%4661585.465+249%6402871.287+154%6402871.287+154%
Usd Total Gains Per Share---0.007-0.018+183%0.157-104%0.094-107%0.094-107%
 EOD+3 -3MRQTTM+24 -8YOY+19 -135Y+20 -1210Y+20 -12

3.2. Fundamental Score

Let's check the fundamental score of Enzychem Lifesciences Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-20.426
Price to Book Ratio (EOD)Between0-10.769
Net Profit Margin (MRQ)Greater than0-0.079
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.432
Current Ratio (MRQ)Greater than112.327
Debt to Asset Ratio (MRQ)Less than10.080
Debt to Equity Ratio (MRQ)Less than10.087
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.009
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Enzychem Lifesciences Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.203
Ma 20Greater thanMa 501,841.100
Ma 50Greater thanMa 1001,754.460
Ma 100Greater thanMa 2001,748.730
OpenGreater thanClose1,718.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets211,545,507
Total Liabilities16,918,865
Total Stockholder Equity193,515,937
 As reported
Total Liabilities 16,918,865
Total Stockholder Equity+ 193,515,937
Total Assets = 211,545,507

Assets

Total Assets211,545,507
Total Current Assets174,475,031
Long-term Assets37,070,476
Total Current Assets
Cash And Cash Equivalents 15,470,224
Short-term Investments 121,879,997
Net Receivables 11,625,325
Inventory 14,945,872
Other Current Assets 44,941
Total Current Assets  (as reported)174,475,031
Total Current Assets  (calculated)163,966,359
+/- 10,508,672
Long-term Assets
Property Plant Equipment 26,164,189
Goodwill 1,479,504
Intangible Assets 4,371,453
Long-term Assets  (as reported)37,070,476
Long-term Assets  (calculated)32,015,146
+/- 5,055,330

Liabilities & Shareholders' Equity

Total Current Liabilities14,154,097
Long-term Liabilities2,764,768
Total Stockholder Equity193,515,937
Total Current Liabilities
Short Long Term Debt 3,393,320
Accounts payable 6,493,196
Other Current Liabilities 50,139
Total Current Liabilities  (as reported)14,154,097
Total Current Liabilities  (calculated)9,936,655
+/- 4,217,442
Long-term Liabilities
Long term Debt 1,025,000
Capital Lease Obligations Min Short Term Debt1,238,639
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)2,764,768
Long-term Liabilities  (calculated)2,263,639
+/- 501,129
Total Stockholder Equity
Retained Earnings 41,910,074
Total Stockholder Equity (as reported)193,515,937
Total Stockholder Equity (calculated)41,910,074
+/- 151,605,863
Other
Capital Stock42,532,781
Common Stock Shares Outstanding 85,066
Net Invested Capital 197,934,257
Net Working Capital 160,320,934
Property Plant and Equipment Gross 41,363,019



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
69,930,620
92,306,988
90,999,525
84,991,166
82,174,644
84,152,883
83,622,810
123,802,206
150,399,690
144,710,691
140,034,236
133,084,134
281,757,911
280,773,084
275,092,568
247,554,987
219,993,763
214,371,852
216,222,307
211,545,507
211,545,507216,222,307214,371,852219,993,763247,554,987275,092,568280,773,084281,757,911133,084,134140,034,236144,710,691150,399,690123,802,20683,622,81084,152,88382,174,64484,991,16690,999,52592,306,98869,930,620
   > Total Current Assets 
52,377,490
74,949,625
59,021,654
63,236,295
61,090,451
62,546,686
64,470,103
104,998,821
131,334,695
125,420,024
120,451,354
109,783,112
257,181,418
253,027,300
245,830,728
220,312,758
184,240,674
177,567,609
179,355,521
174,475,031
174,475,031179,355,521177,567,609184,240,674220,312,758245,830,728253,027,300257,181,418109,783,112120,451,354125,420,024131,334,695104,998,82164,470,10362,546,68661,090,45163,236,29559,021,65474,949,62552,377,490
       Cash And Cash Equivalents 
1,251,185
10,948,579
1,868,878
2,287,757
1,092,832
3,763,581
1,436,218
1,857,600
25,680,965
11,046,982
8,426,281
2,784,141
3,676,150
3,373,931
1,273,396
7,683,080
3,371,965
8,102,837
4,672,844
15,470,224
15,470,2244,672,8448,102,8373,371,9657,683,0801,273,3963,373,9313,676,1502,784,1418,426,28111,046,98225,680,9651,857,6001,436,2183,763,5811,092,8322,287,7571,868,87810,948,5791,251,185
       Short-term Investments 
32,109,663
46,347,141
38,354,977
43,337,182
41,560,650
41,349,367
45,640,609
88,645,953
89,052,600
99,052,600
98,802,600
91,802,600
235,802,600
230,402,600
226,872,600
185,172,600
156,466,097
143,584,252
140,683,591
121,879,997
121,879,997140,683,591143,584,252156,466,097185,172,600226,872,600230,402,600235,802,60091,802,60098,802,60099,052,60089,052,60088,645,95345,640,60941,349,36741,560,65043,337,18238,354,97746,347,14132,109,663
       Net Receivables 
10,110,316
9,186,678
9,566,043
8,668,475
10,260,255
8,768,324
6,566,216
4,185,713
4,604,752
5,804,148
4,506,130
5,206,146
7,407,851
6,076,307
4,237,979
6,357,781
6,129,172
8,486,137
13,022,771
11,625,325
11,625,32513,022,7718,486,1376,129,1726,357,7814,237,9796,076,3077,407,8515,206,1464,506,1305,804,1484,604,7524,185,7136,566,2168,768,32410,260,2558,668,4759,566,0439,186,67810,110,316
       Inventory 
8,269,889
7,452,394
7,968,731
7,846,630
7,353,764
7,803,342
9,581,099
9,177,837
10,023,544
7,997,758
7,572,489
8,355,105
8,630,787
10,095,123
9,919,084
9,794,178
12,616,838
13,771,189
14,401,138
14,945,872
14,945,87214,401,13813,771,18912,616,8389,794,1789,919,08410,095,1238,630,7878,355,1057,572,4897,997,75810,023,5449,177,8379,581,0997,803,3427,353,7647,846,6307,968,7317,452,3948,269,889
       Other Current Assets 
1
0
-1
177,107
199,413
191,017
131,769
150,264
127,699
167,172
178,782
134,216
136,309
158,884
143,387
77,576
77,856
96,930
121,998
44,941
44,941121,99896,93077,85677,576143,387158,884136,309134,216178,782167,172127,699150,264131,769191,017199,413177,107-101
   > Long-term Assets 
17,553,130
17,357,363
31,977,871
21,754,872
21,084,193
21,606,198
19,152,707
18,803,385
19,064,995
19,290,667
19,582,882
23,301,022
24,576,493
27,745,785
29,261,840
27,242,229
35,753,089
36,804,243
36,866,786
37,070,476
37,070,47636,866,78636,804,24335,753,08927,242,22929,261,84027,745,78524,576,49323,301,02219,582,88219,290,66719,064,99518,803,38519,152,70721,606,19821,084,19321,754,87231,977,87117,357,36317,553,130
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,514,138
23,293,603
25,298,970
26,017,789
26,190,049
26,164,189
26,164,18926,190,04926,017,78925,298,97023,293,60320,514,13800000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,330,413
1,394,502
1,394,502
1,479,504
1,479,5041,394,5021,394,5024,330,4130000000000000000
       Intangible Assets 
1,029,547
1,004,774
974,578
1,571,045
1,612,247
1,576,699
1,998,837
1,969,506
2,136,693
2,167,852
2,292,766
6,469,320
6,994,058
6,997,525
7,000,807
2,185,695
2,247,934
4,723,580
4,571,579
4,371,453
4,371,4534,571,5794,723,5802,247,9342,185,6957,000,8076,997,5256,994,0586,469,3202,292,7662,167,8522,136,6931,969,5061,998,8371,576,6991,612,2471,571,045974,5781,004,7741,029,547
       Long-term Assets Other 
17,553,130
17,357,363
0
21,754,872
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-100000000000000021,754,872017,357,36317,553,130
> Total Liabilities 
11,481,873
11,336,465
11,208,068
10,950,625
12,160,589
17,795,626
22,446,507
51,319,666
54,898,599
55,650,496
57,679,462
58,422,236
59,462,542
63,730,031
63,299,370
45,810,907
19,895,357
16,214,284
20,801,465
16,918,865
16,918,86520,801,46516,214,28419,895,35745,810,90763,299,37063,730,03159,462,54258,422,23657,679,46255,650,49654,898,59951,319,66622,446,50717,795,62612,160,58910,950,62511,208,06811,336,46511,481,873
   > Total Current Liabilities 
9,454,368
7,989,043
7,984,446
7,498,917
8,796,706
9,799,201
11,394,823
9,783,831
12,409,557
12,130,340
13,117,091
53,620,512
55,886,100
61,023,770
60,992,602
42,284,411
16,280,269
11,067,428
15,330,424
14,154,097
14,154,09715,330,42411,067,42816,280,26942,284,41160,992,60261,023,77055,886,10053,620,51213,117,09112,130,34012,409,5579,783,83111,394,8239,799,2018,796,7067,498,9177,984,4467,989,0439,454,368
       Short-term Debt 
3,357,000
2,676,000
3,174,156
2,614,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,614,0003,174,1562,676,0003,357,000
       Short Long Term Debt 
3,357,000
2,676,000
3,174,156
2,614,000
2,962,086
4,800,378
5,750,871
5,438,400
6,875,060
7,591,720
7,966,640
48,495,784
50,844,057
54,171,747
56,745,478
36,241,796
7,996,640
4,171,640
4,008,800
3,393,320
3,393,3204,008,8004,171,6407,996,64036,241,79656,745,47854,171,74750,844,05748,495,7847,966,6407,591,7206,875,0605,438,4005,750,8714,800,3782,962,0862,614,0003,174,1562,676,0003,357,000
       Accounts payable 
4,085,274
1,676,286
3,454,810
2,737,686
2,578,186
2,770,518
2,111,498
867,651
2,068,398
1,727,906
2,148,734
2,250,328
1,783,828
3,015,101
2,375,561
1,496,037
3,371,168
2,940,537
6,998,477
6,493,196
6,493,1966,998,4772,940,5373,371,1681,496,0372,375,5613,015,1011,783,8282,250,3282,148,7341,727,9062,068,398867,6512,111,4982,770,5182,578,1862,737,6863,454,8101,676,2864,085,274
       Other Current Liabilities 
0
1
0
199,223
221,309
210,055
145,249
167,385
150,316
174,468
185,682
137,987
147,967
168,203
153,522
84,646
90,633
107,156
136,640
50,139
50,139136,640107,15690,63384,646153,522168,203147,967137,987185,682174,468150,316167,385145,249210,055221,309199,223010
   > Long-term Liabilities 
2,027,506
3,347,422
3,223,622
3,451,708
3,363,883
7,996,425
11,051,684
41,535,834
42,489,042
43,520,156
44,562,371
4,801,724
3,576,442
2,706,261
2,306,769
3,526,495
3,615,089
5,146,856
5,471,041
2,764,768
2,764,7685,471,0415,146,8563,615,0893,526,4952,306,7692,706,2613,576,4424,801,72444,562,37143,520,15642,489,04241,535,83411,051,6847,996,4253,363,8833,451,7083,223,6223,347,4222,027,506
       Long term Debt 
150,000
0
0
0
0
4,100,000
6,758,260
37,119,721
38,464,893
39,957,965
41,592,781
3,174,960
2,458,300
1,741,640
1,024,980
683,320
389,160
1,040,000
1,032,500
1,025,000
1,025,0001,032,5001,040,000389,160683,3201,024,9801,741,6402,458,3003,174,96041,592,78139,957,96538,464,89337,119,7216,758,2604,100,0000000150,000
       Capital Lease Obligations 
466,900
601,670
554,893
475,531
563,218
468,484
409,793
508,396
636,427
620,266
477,589
306,676
775,117
768,555
671,566
853,725
1,134,687
970,404
1,052,391
1,238,639
1,238,6391,052,391970,4041,134,687853,725671,566768,555775,117306,676477,589620,266636,427508,396409,793468,484563,218475,531554,893601,670466,900
       Long-term Liabilities Other 
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001
> Total Stockholder Equity
58,448,747
80,970,523
79,791,456
74,040,541
70,014,055
66,357,257
61,176,304
72,482,540
95,501,091
89,060,195
82,354,774
74,661,898
222,295,369
217,043,053
211,793,198
201,744,080
199,411,181
196,955,412
194,328,023
193,515,937
193,515,937194,328,023196,955,412199,411,181201,744,080211,793,198217,043,053222,295,36974,661,89882,354,77489,060,19595,501,09172,482,54061,176,30466,357,25770,014,05574,040,54179,791,45680,970,52358,448,747
   Common Stock00000000000000000000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 00000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue76,038,894
Cost of Revenue-71,690,744
Gross Profit4,348,1504,348,150
 
Operating Income (+$)
Gross Profit4,348,150
Operating Expense-90,395,039
Operating Income-14,356,145-86,046,888
 
Operating Expense (+$)
Research Development5,433,778
Selling General Administrative6,197,891
Selling And Marketing Expenses0
Operating Expense90,395,03911,631,669
 
Net Interest Income (+$)
Interest Income5,489,404
Interest Expense-620,094
Other Finance Cost-0
Net Interest Income4,869,310
 
Pretax Income (+$)
Operating Income-14,356,145
Net Interest Income4,869,310
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,878,952-14,356,145
EBIT - interestExpense = -620,094
-9,326,412
-8,706,317
Interest Expense620,094
Earnings Before Interest and Taxes (EBIT)0-9,258,858
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-9,878,952
Tax Provision--476,300
Net Income From Continuing Ops-9,402,652-9,402,652
Net Income-9,326,412
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,869,310
 

Technical Analysis of Enzychem Lifesciences Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Enzychem Lifesciences Corporation. The general trend of Enzychem Lifesciences Corporation is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Enzychem Lifesciences Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Enzychem Lifesciences Corporation.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2,080 < 2,265 < 2,290.

The bearish price targets are: 1,718 > 1,564 > 1,505.

Tweet this
Enzychem Lifesciences Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Enzychem Lifesciences Corporation. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Enzychem Lifesciences Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Enzychem Lifesciences Corporation. The current macd is -7.33410169.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enzychem Lifesciences Corporation price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Enzychem Lifesciences Corporation. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Enzychem Lifesciences Corporation price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Enzychem Lifesciences Corporation Daily Moving Average Convergence/Divergence (MACD) ChartEnzychem Lifesciences Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Enzychem Lifesciences Corporation. The current adx is 19.33.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Enzychem Lifesciences Corporation shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Enzychem Lifesciences Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Enzychem Lifesciences Corporation. The current sar is 1,789.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Enzychem Lifesciences Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Enzychem Lifesciences Corporation. The current rsi is 46.20. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Enzychem Lifesciences Corporation Daily Relative Strength Index (RSI) ChartEnzychem Lifesciences Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Enzychem Lifesciences Corporation. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Enzychem Lifesciences Corporation price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Enzychem Lifesciences Corporation Daily Stochastic Oscillator ChartEnzychem Lifesciences Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Enzychem Lifesciences Corporation. The current cci is -84.35094334.

Enzychem Lifesciences Corporation Daily Commodity Channel Index (CCI) ChartEnzychem Lifesciences Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Enzychem Lifesciences Corporation. The current cmo is -12.79872237.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Enzychem Lifesciences Corporation Daily Chande Momentum Oscillator (CMO) ChartEnzychem Lifesciences Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Enzychem Lifesciences Corporation. The current willr is -67.37967914.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Enzychem Lifesciences Corporation is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Enzychem Lifesciences Corporation Daily Williams %R ChartEnzychem Lifesciences Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Enzychem Lifesciences Corporation.

Enzychem Lifesciences Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Enzychem Lifesciences Corporation. The current atr is 69.88.

Enzychem Lifesciences Corporation Daily Average True Range (ATR) ChartEnzychem Lifesciences Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Enzychem Lifesciences Corporation. The current obv is 10,907,507.

Enzychem Lifesciences Corporation Daily On-Balance Volume (OBV) ChartEnzychem Lifesciences Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Enzychem Lifesciences Corporation. The current mfi is 38.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Enzychem Lifesciences Corporation Daily Money Flow Index (MFI) ChartEnzychem Lifesciences Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Enzychem Lifesciences Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Enzychem Lifesciences Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Enzychem Lifesciences Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.203
Ma 20Greater thanMa 501,841.100
Ma 50Greater thanMa 1001,754.460
Ma 100Greater thanMa 2001,748.730
OpenGreater thanClose1,718.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Enzychem Lifesciences Corporation with someone you think should read this too:
  • Are you bullish or bearish on Enzychem Lifesciences Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Enzychem Lifesciences Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Enzychem Lifesciences Corporation

I send you an email if I find something interesting about Enzychem Lifesciences Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Enzychem Lifesciences Corporation.

Receive notifications about Enzychem Lifesciences Corporation in your mailbox!